Pelage Pharmaceuticals
Pelage Pharmaceuticals is a clinical-stage regenerative medicine company developing first-in-class treatments for hair loss. With a focus on stem cell biology and metabolism, Pelage is advancing a new class of treatments designed to reactivate dormant hair follicle stem cells and restore the body’s ability to naturally grow hair. Its lead program, PP405, is currently in Phase 2a clinical trials. Through its rigorous scientific foundation, Pelage is pioneering first-in-class hair growth solutions for people of all hair types experiencing hair loss. To stay in the loop on future trials for PP405, sign up for emails at https://pelagepp405.com/
7-day free trial · no credit card
Verified contacts
8
available on Kipplo
LinkedIn employees
10
1 to 10 range
Open roles
—
no listings
Distinct roles
5
indexed titles
Tech stack
1
tools in use
Monthly traffic
—
organic / mo
Sign up free to see all 8 verified contacts at Pelage Pharmaceuticals
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
8 contacts with verified email or phone · masked until revealed.
- AF
Aimee Flores
Director Translational Medicine · Research & Development
EmailPhone - TM
Tess McDaniel
Laboratory Manager · Science
EmailPhone - LF
Leslie Flores
Associate Researcher · Research & Development
EmailPhone - DG
Daniel Gil
Chief Executive Officer · General Business & Management
EmailPhone
Showing 4 of 8 verified contacts
Top roles at Pelage Pharmaceuticals
5 distinct titles indexed · top 5 shown.
- 1associate researcher
- 1bioinformatics scientist
- 1chief executive officer
- 1director translational medicine
- 1laboratory manager
Sign up to unlock all 8 contacts at Pelage Pharmaceuticals
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 8 verified contacts at Pelage Pharmaceuticals
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.